Willize E. van der Starre

Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection

Willize E. van der Starre, Cees van Nieuwkoop, S. Paltansing et al. · Journal of Antimicrobial Chemotherapy · 2010 · 117 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women

Cees van Nieuwkoop, Willize E. van der Starre, Janneke E. Stalenhoef et al. · BMC Medicine · 2017 · 85 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infections

Feng Jung Sherida H. Woei-A-Jin, Willize E. van der Starre, Margot Tesselaar et al. · Thrombosis Research · 2014 · 41 citations

Life Sciences, Immunology, Infectious Diseases +13

Urinary Proteins, Vitamin D and Genetic Polymorphisms as Risk Factors for Febrile Urinary Tract Infection and Relation with Bacteremia: A Case Control Study

Willize E. van der Starre, Cees van Nieuwkoop, Uginia Thomson et al. · PLoS ONE · 2015 · 30 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection

Janneke E. Stalenhoef, Cees van Nieuwkoop, Darius Cameron Wilson et al. · BMC Infectious Diseases · 2019 · 28 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16